NCT04238104

Brief Summary

major CHD (Congenital Heart Disease) screening by POX (pulse oximetry) in sea-level areas is not fit for low, medium and high altitude areas, but the normal range of pulse oximetry at different altitude areas has not been studied before, so the current screening technology can only be used in sea-level areas, but not for newborns in low, medium and high altitude areas. We need to carry out a research to clarify the range of POX and make sure the threshold of POX in major CHD screening in different altitude areas of China.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

8 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 26, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 23, 2020

Completed
9 days until next milestone

Study Start

First participant enrolled

February 1, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2021

Completed
Last Updated

July 28, 2021

Status Verified

December 1, 2020

Enrollment Period

1.2 years

First QC Date

November 26, 2019

Last Update Submit

July 26, 2021

Conditions

Keywords

SaturationCut-off valueNeonatesAltitudePOXmajor CHD

Outcome Measures

Primary Outcomes (1)

  • Pulse oximetry of healthy newborns at 6th hour after birth at different altitudes

    Pulse oximetry of healthy newborns at 6th hour after birth would be measured by monitor at 6th hour after birth and would be described by range interquartile in healthy neonates in hospitals with different altitudes. Altitude levels :sea level, within 1000 meters above sea level, 1000 to 2000 meters above sea level, 2000 to 3000 meters above sea level, 3000 to 4000 meters above sea level and 4000 to 5000 meters above sea level.

    At 6th hours after birth

Secondary Outcomes (9)

  • Pulse oximetry of healthy newborns at 12th hour after birth at different altitudes

    At 12th hours after birth

  • Pulse oximetry of healthy newborns at 24th hour after birth at different altitudes

    At 24th hours after birth

  • Pulse oximetry of healthy newborns at 48th hour after birth at different altitudes

    At 48th hours after birth

  • Pulse oximetry of healthy newborns at 72th hour after birth at different altitudes

    At 72th hours after birth

  • Pulse oximetry of newborns with critical congenital heart disease at 6th hour after birth at different altitudes

    At 6th hours after birth

  • +4 more secondary outcomes

Study Arms (6)

sea level

Pulse oximetry was performed between 6 and 72 hours after delivery (measured and recorded at 6, 12, 24, 48 and 72 hours respectively). Using Masimo Radical-7 (Irvine, CA, USA) to measure. All measurements at the medical center of sea level were performed by the well-trained investigator. All major CHD infants will be measured the POX by the same way during the whole study period.

Other: no intervention

altitude <1000

Pulse oximetry was performed between 6 and 72 hours after delivery (measured and recorded at 6, 12, 24, 48 and 72 hours respectively). Using Masimo Radical-7 (Irvine, CA, USA) to measure. All measurements at the medical center with the altitude less than 1000 metres were performed by the well-trained investigator. All major CHD infants will be measured the POX by the same way during the whole study period.

Other: no intervention

altitude 1000-2000

Pulse oximetry was performed between 6 and 72 hours after delivery (measured and recorded at 6, 12, 24, 48 and 72 hours respectively). Using Masimo Radical-7 (Irvine, CA, USA) to measure. All measurements at the medical center with the altitude between 1000-2000 metres were performed by the well-trained investigator. All major CHD infants will be measured the POX by the same way during the whole study period.

Other: no intervention

altitude 2000-3000

Pulse oximetry was performed between 6 and 72 hours after delivery (measured and recorded at 6, 12, 24, 48 and 72 hours respectively). Using Masimo Radical-7 (Irvine, CA, USA) to measure. All measurements at the medical center with the altitude between 2000-3000 metres were performed by the well-trained investigator. All major CHD infants will be measured the POX by the same way during the whole study period.

Other: no intervention

altitude 3000-4000

Pulse oximetry was performed between 6 and 72 hours after delivery (measured and recorded at 6, 12, 24, 48 and 72 hours respectively). Using Masimo Radical-7 (Irvine, CA, USA) to measure. All measurements at the medical center with the altitude between 3000-4000 metres were performed by the well-trained investigator. All major CHD infants will be measured the POX by the same way during the whole study period.

Other: no intervention

altitude 4000-5000

Pulse oximetry was performed between 6 and 72 hours after delivery (measured and recorded at 6, 12, 24, 48 and 72 hours respectively). Using Masimo Radical-7 (Irvine, CA, USA) to measure. All measurements at the medical center with the altitude between 4000-5000 metres were performed by the well-trained investigator. All major CHD infants will be measured the POX by the same way during the whole study period.

Other: no intervention

Interventions

it's only observational study. No interventions.

altitude 1000-2000altitude 2000-3000altitude 3000-4000altitude 4000-5000altitude <1000sea level

Eligibility Criteria

AgeUp to 28 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

During the study period (January 15, 2019 to December 15, 2020), all newborns in continuous delivery were included simultaneously in various medical centers in different altitude areas. For major CHD infants, the study period will be January 15, 2019 to December 15, 2020.

You may qualify if:

  • For healthy newborns:
  • Healthy, asymptomatic, singleton term infants (37-41 weeks gestation);
  • Appropriate for gestational age (using the international WHO's intrauterine growth curve to evaluate);
  • Only newborns with Apgar score ≥ 7 in 1 minute and 5 minutes were selected;
  • There is no known congenital heart disease based on the ECHO result , no murmur, no obvious signs (no fever, no tachycardia or respiratory symptoms at the time of admission).
  • For major CHD newborns:
  • Echocardiography clearly diagnosed the following congenital heart diseases: Aortic stenosis, Double outlet of right ventricle, Ebstein's malformation, Left cardiac hypoplasia syndrome, Aortic arch disconnection, Pulmonary atresia, Single ventricle, Tetralogy of Fallot, Complete anomalous pulmonary venous drainage, Transposition of great arteries, Tricuspid valve atresia, and Single trunk of arteries and other major CHD based on Ewer's denition.

You may not qualify if:

  • For healthy newborns:
  • Newborn with caesarean section; newborn with smoking mother; newborn with definite congenital heart disease before discharge.
  • For major CHD newborns:

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

People's Hospital of Golog Tibetan Autonomous Prefecture

Guoluo Prefecture, China

Location

Hainan women and children medical center

Haikou, China

Location

Yan'an Hospital Affiliated to Kunming Medical University

Kunming, China

Location

Tibet Autonomous People's Hospital

Lhasa, China

Location

People's Hospital of Luchun County, Yunnan Province

Luchun, China

Location

People's Hospital of Naqu District, Tibet

Naqu, China

Location

Qinghai Red Cross Hospital

Qinghai, China

Location

People's Hospital of Xinjiang Uygur Autonomous Region

Ürümqi, China

Location

Study Officials

  • Weili Yan, PhD

    Epidemiology Office of Children's hospital of Fudan University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2019

First Posted

January 23, 2020

Study Start

February 1, 2020

Primary Completion

April 15, 2021

Study Completion

April 15, 2021

Last Updated

July 28, 2021

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations